Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

9.25
Delayed Data
As of Mar 24
 +0.05 / +0.54%
Today’s Change
7.75
Today|||52-Week Range
37.20
-30.19%
Year-to-Date

Today’s Trading

Previous close9.20
Today’s open9.20
Day’s range9.10 - 9.38
Volume593,380
Average volume (3 months)1,669,665
Market cap$682.2M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-31.83%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc+0.50+4.59%
ADROAduro Biotech Inc-0.20-1.93%
HSKAHeska Corp+0.49+0.50%
CTMXCytomX Therapeutics ...+0.37+2.12%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs